Difference between revisions of "LncRNAWiki:O"
| Line 34: | Line 34: | ||
|ovarian cancer | |ovarian cancer | ||
|- | |- | ||
| + | |''PAX8-AS1'' | ||
| + | |[[PAX8-AS1]] | ||
| + | |N/A | ||
| + | |PAX8 antisense RNA 1 | ||
| + | |cervical cancer | ||
| + | |- | ||
| + | |''PINCR'' | ||
| + | |[[PINCR]] | ||
| + | |N/A | ||
| + | |p53-induced noncoding RNA | ||
| + | |Colorectal cancer | ||
| + | |- | ||
| + | |''PLUT'' | ||
| + | |[[PLUT]] | ||
| + | |PDX1-AS1, PLUTO, HI-LNC71 | ||
| + | |PDX1 associated lncRNA, upregulator of transcription | ||
| + | |Type 2 diabetes | ||
| + | |- | ||
| + | |''PRAL'' | ||
| + | |[[PRAL]] | ||
| + | |lncRNA-PRAL | ||
| + | |p53 regulation associated lncRNA | ||
| + | |Hepatocellular carcinoma, Lung Cancer | ||
| + | |- | ||
| + | |''PRKCZ-AS1'' | ||
| + | |[[PRKCZ-AS1]] | ||
| + | |RP11-181G12.2 | ||
| + | |PRKCZ antisense RNA 1 | ||
| + | |lung adenocarcinoma | ||
| + | |- | ||
| + | |''PRKG1-AS1'' | ||
| + | |[[PRKG1-AS1]] | ||
| + | |RP11-573I11.2 | ||
| + | |PRKG1 antisense RNA 1 | ||
| + | |rheumatoid arthritis | ||
| + | |- | ||
| + | |''PSMD6-AS1'' | ||
| + | |[[PSMD6-AS1]] | ||
| + | |ENST00000462717, lnc00462717 | ||
| + | |PSMD6 antisense RNA 1 | ||
| + | |Papillary Thyroid Cancer, GBM | ||
| + | |- | ||
| + | |''PSORS1C3'' | ||
| + | |[[PSORS1C3]] | ||
| + | |NCRNA00196 | ||
| + | |psoriasis susceptibility 1 candidate 3 (non-protein coding) | ||
| + | |rheumatoid arthritis | ||
| + | |- | ||
| + | |''PSPC1-AS2'' | ||
| + | |[[PSPC1-AS2]] | ||
| + | |RP11-523H24.3 | ||
| + | |PSPC1 antisense RNA 2 | ||
| + | |esophageal squamous cell carcinoma | ||
|} | |} | ||
Latest revision as of 09:28, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| OIP5-AS1 | ENST00000500949.2 | "cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1" | OIP5 antisense RNA 1 | _ |
| OLMALINC | OLMALINC | "bA34D15.5, FLJ12974, HI-LNC80" | oligodendrocyte maturation-associated long intergenic non-coding RNA | _ |
| OTX2-AS1 | lnc-C14orf101-5:1 | "OTX2OS1, ENSG00000248550" | OTX2 antisense RNA 1 (head to head) | _ |
| OVAAL | ENST00000442621.1 | "LINC01131,OVAL" | ovarian adenocarcinoma amplified long non-coding RNA | ovarian cancer |
| PAX8-AS1 | PAX8-AS1 | N/A | PAX8 antisense RNA 1 | cervical cancer |
| PINCR | PINCR | N/A | p53-induced noncoding RNA | Colorectal cancer |
| PLUT | PLUT | PDX1-AS1, PLUTO, HI-LNC71 | PDX1 associated lncRNA, upregulator of transcription | Type 2 diabetes |
| PRAL | PRAL | lncRNA-PRAL | p53 regulation associated lncRNA | Hepatocellular carcinoma, Lung Cancer |
| PRKCZ-AS1 | PRKCZ-AS1 | RP11-181G12.2 | PRKCZ antisense RNA 1 | lung adenocarcinoma |
| PRKG1-AS1 | PRKG1-AS1 | RP11-573I11.2 | PRKG1 antisense RNA 1 | rheumatoid arthritis |
| PSMD6-AS1 | PSMD6-AS1 | ENST00000462717, lnc00462717 | PSMD6 antisense RNA 1 | Papillary Thyroid Cancer, GBM |
| PSORS1C3 | PSORS1C3 | NCRNA00196 | psoriasis susceptibility 1 candidate 3 (non-protein coding) | rheumatoid arthritis |
| PSPC1-AS2 | PSPC1-AS2 | RP11-523H24.3 | PSPC1 antisense RNA 2 | esophageal squamous cell carcinoma |
